Etoricoxib

prostaglandin-endoperoxide synthase 2 ; Homo sapiens







69 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33429006 COX-2 promotes mammary adipose tissue inflammation, local estrogen biosynthesis, and carcinogenesis in high-sugar/fat diet treated mice. 2021 Apr 1 1
2 33468439 Probable etoricoxib-induced fixed drug eruption involving the oral mucosa: A case report. 2021 Apr 1
3 33730601 Etoricoxib may inhibit cytokine storm to treat COVID-19. 2021 May 1
4 34811370 A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients. 2021 Nov 22 1
5 32303303 Detection and Pharmacokinetics of Etoricoxib in Thoroughbred Horses. 2020 May 1
6 32912981 Comparative efficacy of traditional non-selective NSAIDs and selective cyclo-oxygenase-2 inhibitors in patients with acute gout: a systematic review and meta-analysis. 2020 Sep 10 1
7 30080442 Exploring the binding dynamics of etoricoxib with human hemoglobin: A spectroscopic, calorimetric, and molecular modeling approach. 2019 Jul 1
8 31190596 Utilization of etoricoxib in dental patients in the Nordic countries: a population-based register study. 2019 Nov 1
9 31360199 Expression of microRNAs in the plasma of patients with acute gouty arthritis and the effects of colchicine and etoricoxib on the differential expression of microRNAs. 2019 Jul 1
10 28954205 Etoricoxib improves osteoarthritis pain relief, joint function, and quality of life in the extreme elderly. 2018 Feb 20 1
11 28425581 Clinical, Biochemical, and Genetic Features of 41 Han Chinese Families With Primary Hypertrophic Osteoarthropathy, and Their Therapeutic Response to Etoricoxib: Results From a Six-Month Prospective Clinical Intervention. 2017 Aug 1
12 28464042 Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial. 2017 1
13 25828692 No effect of the cyclooxygenase-2 inhibitor etoricoxib on pre-emptive and post-operative analgesia in visceral surgery: results of a randomized controlled trial. 2016 Feb 1
14 27372432 Selective COX-2 Inhibition Exerts No Negative Effects on Peripheral Blood Lymphocytes in Allergic Asthmatics. 2016 2
15 26548623 Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed. 2015 Dec 15 1
16 25340915 Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease. 2014 Oct 23 1
17 22882551 The first example of a patient with etoricoxib-induced immune hemolytic anemia. 2013 May 1
18 23652751 Increased risk for complications after colorectal surgery with selective cyclo-oxygenase 2 inhibitor etoricoxib. 2013 Jun 1
19 23126318 Etoricoxib and the treatment of ankylosing spondylitis. 2012 Dec 1
20 21235334 The use of etoricoxib and celecoxib for pain prevention after periodontal surgery: a double-masked, parallel-group, placebo-controlled, randomized clinical trial. 2011 Sep 1
21 21332932 Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo. 2011 Mar 1
22 21457143 Inhibitory effect of selective cyclooxygenase-2 inhibitor etoricoxib on human organic anion transporter 3 (hOAT3). 2011 Apr 2
23 21618455 Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies. 2011 Sep 2
24 20039959 Prophylactic etoricoxib is effective in preventing Yom Kippur headache: a placebo-controlled double-blind and randomized trial of prophylaxis for ritual fasting headache. 2010 Sep 1
25 20052461 Absorption and distribution of etoricoxib in plasma, CSF, and wound tissue in patients following hip surgery--a pilot study. 2010 Feb 1
26 20584877 Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol. 2010 Aug 1
27 20877132 Inhibitory effect of selective cyclooxygenase-2 inhibitor lumiracoxib on human organic anion transporters hOAT1 and hOAT3. 2010 1
28 18952694 Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation. 2009 Feb 1 1
29 19338584 Synthesis of hyaluronan in oesophageal cancer cells is uncoupled from the prostaglandin-cAMP pathway. 2009 May 1
30 19392653 The cyclooxygenase-2 inhibitor etoricoxib is a potent chemopreventive agent of colon carcinogenesis in the rat model. 2009 2
31 18405470 Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. 2008 Apr 3
32 18443385 Effects of etoricoxib on the pharmacokinetics of phenytoin. 2008 Mar-Apr 2
33 18661871 Design, development, and optimization of orally disintegrating tablets of etoricoxib using vacuum-drying approach. 2008 May-Jun 3
34 18823299 Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib. 2008 Dec 1
35 18823986 Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac. 2008 Nov 1
36 17155937 Etoricoxib pre-medication combined with intra-operative subacromial block for pain after arthroscopic acromioplasty. 2007 Mar 1
37 17228166 Etoricoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs. 2007 1
38 17278926 Therapeutic advances in gout. 2007 Mar 1
39 17304885 Tolerance to etoricoxib in 37 patients with urticaria and angioedema induced by nonsteroidal anti-inflammatory drugs. 2007 Feb 2
40 17691996 Efficacy of the newest COX-2 selective inhibitors in rheumatic disease. 2007 1
41 17697449 Etoricoxib versus naproxen in patients with rheumatoid arthritis: a prospective, randomized, comparator-controlled 121-week trial. 2007 Sep 2
42 17915794 A study on the effects of diclofenac sodium and etoricoxib in the treatment of osteoarthritis. 2007 May 3
43 18516314 Update on the treatment of ankylosing spondylitis. 2007 Dec 1
44 16397127 Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo. 2006 May 1 1
45 16875903 Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis. 2006 Aug 1
46 16892790 Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease. 2006 Jul 2
47 15473012 A liquid chromatography-mass spectrometry method for the quantification of both etoricoxib and valdecoxib in human plasma. 2005 Mar 1
48 15664353 Validated liquid chromatographic ultraviolet method for the quantitation of Etoricoxib in human plasma using liquid-liquid extraction. 2005 Feb 25 1
49 15815733 [COX-2 inhibitors--one step forward and two steps back]. 2005 Apr 7 2
50 15818702 Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study. 2005 Apr 2